Search clinical trials for: Girls Can...Move!

Total 6088 results

Shengyun Lin

Unknown

Clinical Study of Non Severe Aplastic Anemia Treated With Cyclosporine, Androgen and Levamisole

Aplastic Anemia

China
Erasmus Medical Center

Completed

The Effects of Midazolam on the Quality of Postoperative Recovery (WOLII)

Aggression | Depression | Fatigue | Anxiety | Postoperative Period

Netherlands
Eisai Inc.

Completed

An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Colonoscopy

Conscious Sedation

United States
Fred Hutchinson Cancer Center
PromiCell Therapeutics, Inc.

Recruiting

Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

Castration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma

United States
Hospital JP Garrahan
Hospital Pereyra Rosell, Montevideo, Uruguay

Recruiting

Pediatric Hodgkin Lymphoma Treatment Trial With Low Cumulative Doses of Chemotherapy Agents and Reduced Radiation. (LHGALOP2017)

Pediatric Hodgkin's Disease

Argentina
Roswell Park Cancer Institute

Suspended

Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma | Recurrent Hepatocellular Carcinoma | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IV Hepatocellular Carcinoma AJCC v8 | Refractory Hepatocellular Carcinoma | Metastatic Hepatocellular Carcinoma

United States
ViiV Healthcare
GlaxoSmithKline; Janssen Pharmaceuticals

Active, not recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants

HIV Infections

United States, Spain, United Kingdom, South Africa, Japan, Russia
ViiV Healthcare
GlaxoSmithKline; Janssen Pharmaceuticals

Completed

A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects

HIV Infections | Infection, Human Immunodeficiency Virus

Germany, Spain, France, United States, Canada
University of Southern California
National Cancer Institute (NCI)

Active, not recruiting

Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer

Metastatic Renal Cell Cancer | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Healthy Subject | Stage I Renal Cell Cancer | Stage II Renal Cell Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer

Anal Squamous Cell Carcinoma | Stage III Anal Cancer AJCC v8 | Stage IIB Anal Cancer AJCC v8 | Stage IIIA Anal Cancer AJCC v8 | Stage IIIB Anal Cancer AJCC v8 | Stage IIIC Anal Cancer AJCC v8 | Stage I Anal Cancer AJCC v8 | Stage II Anal Cancer AJCC v8 | Stage IIA Anal Cancer AJCC v8 | Stage 0 Anal Cancer...

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas

Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Waldenstrom Macroglobulinemia | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma and other conditions

United States
Chinese PLA General Hospital
Peking University; EdiGene Inc.

Recruiting

TRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL

Non Hodgkin's Lymphoma

China
Ohio State University Comprehensive Cancer Center

Active, not recruiting

Imaging and Blood-Based Biomarkers for the Evaluation of Early Signs of Myocardial Injury After Thoracic Radiation Therapy

Lung Non-Small Cell Carcinoma | GastroEsophageal Cancer | Esophagus Cancer

United States
ViiV Healthcare
GlaxoSmithKline; Janssen Pharmaceuticals

Active, not recruiting

Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults

HIV Infections | Infection, Human Immunodeficiency Virus

Spain, France, Germany, United States, Canada, Australia, South Africa, Italy, Sweden, Argentina, Mexico, South Korea, Russia
Wayne State University

Completed

Effects of Delta-9 Tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R61 Study

PostTraumatic Stress Disorder

United States
Jonsson Comprehensive Cancer Center
Prostate Cancer Foundation

Active, not recruiting

Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation (FAPI PET Prost)

Prostate Carcinoma | Recurrent Prostate Carcinoma | Metastatic Malignant Neoplasm in the Prostate Gland

United States
Thomas Jefferson University

Withdrawn

Virtual Reality for the Improvement of Patients Understanding of Disease and Treatment (MRgRT)

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
C. Babis Andreadis
University of California, Davis

Recruiting

Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

Follicular Lymphoma | Burkitt Lymphoma | Mantle Cell Lymphoma | Lymphoplasmacytic Lymphoma | Non-Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Refractory Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Primary Mediastinal Large B Cell Lymphoma | Transformed Lymphoma

United States
Nair, Vinay, D.O.
Bristol-Myers Squibb; Icahn School of Medicine at Mount Sinai

Unknown

Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function

Kidney Transplant | Delayed Graft Function

United States
Universidade Federal de Goias
Federal University of Minas Gerais

Completed

Midazolam Efficacy for Sedating Preschoolers Undergoing Dental Treatment (Pedsed-I)

Early Childhood Caries

Brazil
Sahlgrenska University Hospital, Sweden

Completed

To Relieve Pain and Anxiety - an Intervention Study in Ambulance Services

Pain | Acute Myocardial Infarction
The Christie NHS Foundation Trust
Merck Sharp & Dohme LLC; University of Manchester; Liverpool Clinical Trials...

Recruiting

The CAPER Trial: A Phase Ib Clinical Trial of Cyclophosphamide And PEmbrolizumab in Metastatic Renal Cell Carcinoma (CAPER)

Metastatic Renal Cell Carcinoma

United Kingdom
Benha University

Completed

Impact of Timing of Midazolam Administration on Incidence of Postoperative Nausea and Vomiting

Postoperative Nausea and Vomiting

Egypt
Takeda

Completed

Phase 1, TAK-915-1001, Single-Rising Dose, Multiple-Rising Dose, Drug-Drug Interaction, Relative Bioavailability, Food Effect, and Effect on Elderly Participants Study

Healthy Volunteers

United States
Memorial Sloan Kettering Cancer Center

Completed

Multiple Respiration-Correlated Cone Beam Computed Tomography (CT) Scans to Reduce Target Positioning Errors in Radiotherapy Treatment of Thoracic Cancer

Esophageal Cancer | Lung Cancer

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating The Co-Administration Of Moxidectin And Midazolam In Healthy Subjects

Healthy

Germany
Eisai Inc.

Completed

Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy

Colonic Polyps | Colonoscopy

United States
Copenhagen University Hospital at Herlev

Unknown

Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl-sedation for Flexible Bronchoscopy: A Randomized, Single Blind, Controlled Study of Satisfaction and Safety.

Sedation | Satisfaction | Safety | Flexible Bronchoscopy

Denmark
National Cancer Institute (NCI)

Active, not recruiting

Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Amplifications (MATCH-Subprotocol K1)

Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma

United States
National Cancer Institute (NCI)

Active, not recruiting

M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Metastatic Pancreatic Carcinoma | Refractory Malignant Solid Neoplasm | Refractory Pancreatic Carcinoma | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Unresectable Pancreatic Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Unresectable Malignant... and other conditions

United States
Northwestern University
National Cancer Institute (NCI)

Not yet recruiting

BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion

Metastatic Pancreatic Carcinoma | Stage IV Pancreatic Cancer AJCC v8 | Metastatic Malignant Solid Neoplasm | Stage IV Colon Cancer AJCC v8 | Metastatic Esophageal Carcinoma | Metastatic Colon Carcinoma | Metastatic Malignant Digestive System Neoplasm | Metastatic Biliary Tract Carcinoma

United States
National Cancer Institute (NCI)

Recruiting

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

Locally Advanced Adrenal Cortical Carcinoma | Metastatic Adrenal Cortical Carcinoma | Stage III Adrenal Cortical Carcinoma AJCC v8 | Stage IV Adrenal Cortical Carcinoma AJCC v8 | Unresectable Adrenal Cortical Carcinoma | Recurrent Adrenal Cortical Carcinoma

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Mutations or Fusions (MATCH - Subprotocol K2)

Malignant Solid Neoplasm

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing LOXO-101 as Potentially Targeted Treatment in Cancers With NTRK Genetic Changes (MATCH - Subprotocol Z1E)

Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma

United States
Haisco Pharmaceutical Group Co., Ltd.

Not yet recruiting

A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Orthopedic Surgery

Pain After Surgery
Haisco Pharmaceutical Group Co., Ltd.

Recruiting

A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal Surgery

Pain After Surgery

China
Second Affiliated Hospital, School of Medicine,...

Not yet recruiting

Efficacy and Safety of Lisafotoclax Plus Decitabine and Homoharringtonine in Venetoclax/Azacitidine Pretreated AML Patients

Acute Myeloid Leukemia (AML)

China
BioCorRx Pharmaceuticals Inc
National Institute on Drug Abuse (NIDA)

Recruiting

Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol

Healthy Adult Male and Female Volunteers

United States
Tata Memorial Hospital

Not yet recruiting

A Clinical Trial to Assess the Effectiveness of NRF2 Activator (Oral Sodium-copper- Chlophyllin ) in Locally Advanced Cervical Cancer to Reduce Late Radiotherapy Toxicity. (CHOC-LATE)

Uterine Cervical Neoplasm
Bin Cao
MicuRx; Beijing Chest Hospital, Capital Medical University; Jiangxi Provincial...

Recruiting

Short-term Bactericidal Effect of Contezolid in MAC-PD (CONTE-MAC)

Mycobacterium Avium Complex Pulmonary Disease

China
Qilu Hospital of Shandong University

Recruiting

Efficacy and Safety Analysis of Polylauric Alcohol More Stable Foam Versus Ordinary Foam in the Treatment of Head and Neck Venous Malformations

Venous Malformation

China
University of Chicago
National Institute on Drug Abuse (NIDA)

Recruiting

Drug Effects on Mood and Behavior - Expectancy (MESA-X)

LSD

United States
University Hospital, Basel, Switzerland
University of Basel; University Psychiatric Clinics Basel

Completed

LSD-Perceptual-Choice-Study (LUCY)

LSD Reaction

Switzerland
Seoul National University Bundang Hospital

Active, not recruiting

Drug-Drug Interaction of Rifampicin and Cyclosporine on Methotrexate Pharmacokinetics in Healthy Subjects (MRCI)

Drug Drug Interaction (DDI)

South Korea
Eli Lilly and Company
Loxo Oncology, Inc.

Completed

A Study of Effects of Itraconazole and Rifampin on Selpercatinib (LY3527723) in Healthy Participants

Healthy

United States
Kyoto University
Osaka University; Mie University; Tokushima University; Asakayama Hospital; Kawasaki... and other collaborators

Completed

Repurposing Bromocriptine for Abeta Metabolism in Alzheimer's Disease (REBRAnD)

Familial Alzheimer Disease (FAD) | PSEN1 Mutation

Japan
Sinai Hospital of Baltimore

Unknown

Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer

Ovarian Cancer | Endometrial Cancer

United States
Ohio State University Comprehensive Cancer Center

Not yet recruiting

Minoxidil With or Without Low-Level Red-Light Therapy for Improving Chemotherapy-Induced Alopecia in Breast Cancer Patients

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Chemotherapy-Induced Alopecia

United States
Affiliated Hospital to Academy of Military Medical...

Not yet recruiting

CAR BCMA-70 CAR-T Cells for the Treatment of High-risk Plasma Cell Neoplasms

High-risk Plasma Cell Neoplasms

China
Rutgers University

Recruiting

Transdiagnostic Individual Behavioral Activation and Exposure Therapy

Depression | Anxiety Disorders

United States

Search clinical trials for: Girls Can...Move!

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations